US Stock MarketDetailed Quotes

Supernus Pharmaceuticals (SUPN)

Watchlist
  • 49.430
  • -1.770-3.46%
Close May 15 16:00 ET
  • 49.430
  • 0.0000.00%
Post 16:54 ET
2.87BMarket Cap-96.92P/E (TTM)

Supernus Pharmaceuticals (SUPN) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
117.41%66.52M
-72.47%47.33M
-55.27%19.86M
-215.22%-61.66M
64.31%58.54M
-20.32%30.6M
54.79%171.95M
-1.23%44.41M
49.18%53.52M
288.75%35.62M
Net income from continuing operations
80.61%-2.29M
-152.19%-38.55M
-126.78%-4.11M
-217.20%-45.12M
12.97%22.5M
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
Operating gains losses
-333.33%-21K
4,977.78%439K
----
----
----
--9K
---9K
--0
----
----
Depreciation and amortization
28.20%26.13M
13.86%91.56M
32.75%25.02M
23.40%24.81M
3.09%21.36M
-1.76%20.38M
-5.24%80.41M
-13.06%18.85M
-8.03%20.1M
-0.03%20.72M
Deferred tax
248.27%5.92M
125.85%5.21M
26,493.06%19M
59.10%-2.65M
11.74%-7.16M
27.22%-3.99M
21.69%-20.14M
99.31%-72K
30.21%-6.47M
-46.11%-8.12M
Other non cash items
7.78%4.93M
2,047.28%30.38M
1,156.62%20.02M
470.34%3.83M
233.20%1.96M
633.49%4.58M
-71.19%1.42M
133.24%1.59M
-58.11%671K
-121.80%-1.47M
Change In working capital
56.44%21.75M
-3,562.72%-75.16M
-901.31%-51.36M
-523.97%-49.2M
495.87%11.49M
0.30%13.91M
77.54%-2.05M
-359.83%-5.13M
-126.58%-7.89M
93.72%-2.9M
-Change in receivables
257.70%5.62M
-1,173.34%-22.3M
-592.92%-16.42M
-200.64%-7.13M
201.03%4.81M
0.45%-3.56M
-88.93%2.08M
239.37%3.33M
236.03%7.09M
-208.35%-4.76M
-Change in inventory
-102.22%-105K
-147.46%-7.5M
-231.16%-4.18M
-381.06%-12.94M
-18.89%4.89M
137.74%4.73M
158.69%15.81M
-36.61%3.19M
-33.39%4.6M
251.42%6.03M
-Change in prepaid assets
-268.64%-12.43M
31.90%-13.18M
36.12%-6.91M
-535.71%-11.14M
-443.68%-2.5M
198.07%7.37M
-5,694.01%-19.35M
-238.52%-10.81M
-108.59%-1.75M
102.58%728K
-Change in payables and accrued expense
434.33%28.67M
-5,409.25%-32.17M
-2,749.82%-23.85M
-0.91%-17.99M
187.79%4.3M
-76.64%5.37M
98.27%-584K
90.12%-837K
-335.71%-17.82M
73.41%-4.9M
Cash from discontinued investing activities
Operating cash flow
117.41%66.52M
-72.47%47.33M
-55.27%19.86M
-215.22%-61.66M
64.31%58.54M
-20.32%30.6M
54.79%171.95M
-1.23%44.41M
49.18%53.52M
288.75%35.62M
Investing cash flow
Cash flow from continuing investing activities
-151.50%-19.22M
102.16%4.11M
-306.00%-51.31M
163.25%48.71M
37.01%-30.61M
172.29%37.32M
-170.65%-189.87M
80.85%-12.64M
-322.36%-77.01M
-180.59%-48.59M
Net PPE purchase and sale
--0
-84.55%-1.34M
-100.47%-427K
35.50%-129K
-610.94%-455K
-31.85%-327K
-31.58%-725K
-691.67%-213K
-33.33%-200K
59.75%-64K
Net business purchase and sale
----
---293.09M
--0
----
----
----
--0
--0
----
----
Net investment purchase and sale
-151.05%-19.22M
257.84%298.54M
-309.52%-50.88M
545.15%341.93M
37.87%-30.15M
173.27%37.64M
-170.24%-189.14M
81.18%-12.43M
-320.82%-76.81M
-180.27%-48.53M
Cash from discontinued investing activities
Investing cash flow
-151.50%-19.22M
102.16%4.11M
-306.00%-51.31M
163.25%48.71M
37.01%-30.61M
172.29%37.32M
-170.65%-189.87M
80.85%-12.64M
-322.36%-77.01M
-180.59%-48.59M
Financing cash flow
Cash flow from continuing financing activities
142.60%9.12M
-25.12%9.13M
44.75%8.53M
585.14%21.07M
-43.61%935K
-1,462.99%-21.4M
103.06%12.19M
439.38%5.89M
1,436.96%3.08M
100.35%1.66M
Net issuance payments of debt
----
--0
----
----
----
----
--0
--0
--0
--0
Net common stock issuance
569.44%13.67M
152.32%37.62M
24.43%8.56M
585.76%23.74M
97.47%3.28M
-29.83%2.04M
125.54%14.91M
529.76%6.88M
367.84%3.46M
-34.22%1.66M
Net other financing activities
80.57%-4.56M
-949.21%-28.49M
96.86%-31K
-590.70%-2.67M
-234,000.00%-2.34M
-1,649.33%-23.44M
-36.43%-2.72M
---987K
60.10%-387K
99.83%-1K
Cash from discontinued financing activities
Financing cash flow
142.60%9.12M
-25.12%9.13M
44.75%8.53M
585.14%21.07M
-43.61%935K
-1,462.99%-21.4M
103.06%12.19M
439.38%5.89M
1,436.96%3.08M
100.35%1.66M
Net cash flow
Beginning cash position
87.36%129.9M
-7.63%69.33M
382.50%152.82M
177.81%144.71M
82.72%115.85M
-7.63%69.33M
-19.40%75.05M
-66.65%31.67M
110.84%52.09M
-86.28%63.4M
Current changes in cash
21.29%56.42M
1,158.31%60.57M
-160.87%-22.92M
139.72%8.11M
355.15%28.86M
499.18%46.52M
68.32%-5.72M
288.94%37.66M
-129.05%-20.42M
97.41%-11.31M
End cash Position
60.83%186.32M
87.36%129.9M
87.36%129.9M
382.50%152.82M
177.81%144.71M
82.72%115.85M
-7.63%69.33M
-7.63%69.33M
-66.65%31.67M
110.84%52.09M
Free cash flow
119.75%66.52M
-73.14%45.99M
-56.02%19.43M
-215.89%-61.79M
63.33%58.08M
-20.66%30.27M
54.91%171.23M
-1.78%44.19M
49.25%53.32M
286.83%35.56M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 117.41%66.52M-72.47%47.33M-55.27%19.86M-215.22%-61.66M64.31%58.54M-20.32%30.6M54.79%171.95M-1.23%44.41M49.18%53.52M288.75%35.62M
Net income from continuing operations 80.61%-2.29M-152.19%-38.55M-126.78%-4.11M-217.20%-45.12M12.97%22.5M-9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M
Operating gains losses -333.33%-21K4,977.78%439K--------------9K---9K--0--------
Depreciation and amortization 28.20%26.13M13.86%91.56M32.75%25.02M23.40%24.81M3.09%21.36M-1.76%20.38M-5.24%80.41M-13.06%18.85M-8.03%20.1M-0.03%20.72M
Deferred tax 248.27%5.92M125.85%5.21M26,493.06%19M59.10%-2.65M11.74%-7.16M27.22%-3.99M21.69%-20.14M99.31%-72K30.21%-6.47M-46.11%-8.12M
Other non cash items 7.78%4.93M2,047.28%30.38M1,156.62%20.02M470.34%3.83M233.20%1.96M633.49%4.58M-71.19%1.42M133.24%1.59M-58.11%671K-121.80%-1.47M
Change In working capital 56.44%21.75M-3,562.72%-75.16M-901.31%-51.36M-523.97%-49.2M495.87%11.49M0.30%13.91M77.54%-2.05M-359.83%-5.13M-126.58%-7.89M93.72%-2.9M
-Change in receivables 257.70%5.62M-1,173.34%-22.3M-592.92%-16.42M-200.64%-7.13M201.03%4.81M0.45%-3.56M-88.93%2.08M239.37%3.33M236.03%7.09M-208.35%-4.76M
-Change in inventory -102.22%-105K-147.46%-7.5M-231.16%-4.18M-381.06%-12.94M-18.89%4.89M137.74%4.73M158.69%15.81M-36.61%3.19M-33.39%4.6M251.42%6.03M
-Change in prepaid assets -268.64%-12.43M31.90%-13.18M36.12%-6.91M-535.71%-11.14M-443.68%-2.5M198.07%7.37M-5,694.01%-19.35M-238.52%-10.81M-108.59%-1.75M102.58%728K
-Change in payables and accrued expense 434.33%28.67M-5,409.25%-32.17M-2,749.82%-23.85M-0.91%-17.99M187.79%4.3M-76.64%5.37M98.27%-584K90.12%-837K-335.71%-17.82M73.41%-4.9M
Cash from discontinued investing activities
Operating cash flow 117.41%66.52M-72.47%47.33M-55.27%19.86M-215.22%-61.66M64.31%58.54M-20.32%30.6M54.79%171.95M-1.23%44.41M49.18%53.52M288.75%35.62M
Investing cash flow
Cash flow from continuing investing activities -151.50%-19.22M102.16%4.11M-306.00%-51.31M163.25%48.71M37.01%-30.61M172.29%37.32M-170.65%-189.87M80.85%-12.64M-322.36%-77.01M-180.59%-48.59M
Net PPE purchase and sale --0-84.55%-1.34M-100.47%-427K35.50%-129K-610.94%-455K-31.85%-327K-31.58%-725K-691.67%-213K-33.33%-200K59.75%-64K
Net business purchase and sale -------293.09M--0--------------0--0--------
Net investment purchase and sale -151.05%-19.22M257.84%298.54M-309.52%-50.88M545.15%341.93M37.87%-30.15M173.27%37.64M-170.24%-189.14M81.18%-12.43M-320.82%-76.81M-180.27%-48.53M
Cash from discontinued investing activities
Investing cash flow -151.50%-19.22M102.16%4.11M-306.00%-51.31M163.25%48.71M37.01%-30.61M172.29%37.32M-170.65%-189.87M80.85%-12.64M-322.36%-77.01M-180.59%-48.59M
Financing cash flow
Cash flow from continuing financing activities 142.60%9.12M-25.12%9.13M44.75%8.53M585.14%21.07M-43.61%935K-1,462.99%-21.4M103.06%12.19M439.38%5.89M1,436.96%3.08M100.35%1.66M
Net issuance payments of debt ------0------------------0--0--0--0
Net common stock issuance 569.44%13.67M152.32%37.62M24.43%8.56M585.76%23.74M97.47%3.28M-29.83%2.04M125.54%14.91M529.76%6.88M367.84%3.46M-34.22%1.66M
Net other financing activities 80.57%-4.56M-949.21%-28.49M96.86%-31K-590.70%-2.67M-234,000.00%-2.34M-1,649.33%-23.44M-36.43%-2.72M---987K60.10%-387K99.83%-1K
Cash from discontinued financing activities
Financing cash flow 142.60%9.12M-25.12%9.13M44.75%8.53M585.14%21.07M-43.61%935K-1,462.99%-21.4M103.06%12.19M439.38%5.89M1,436.96%3.08M100.35%1.66M
Net cash flow
Beginning cash position 87.36%129.9M-7.63%69.33M382.50%152.82M177.81%144.71M82.72%115.85M-7.63%69.33M-19.40%75.05M-66.65%31.67M110.84%52.09M-86.28%63.4M
Current changes in cash 21.29%56.42M1,158.31%60.57M-160.87%-22.92M139.72%8.11M355.15%28.86M499.18%46.52M68.32%-5.72M288.94%37.66M-129.05%-20.42M97.41%-11.31M
End cash Position 60.83%186.32M87.36%129.9M87.36%129.9M382.50%152.82M177.81%144.71M82.72%115.85M-7.63%69.33M-7.63%69.33M-66.65%31.67M110.84%52.09M
Free cash flow 119.75%66.52M-73.14%45.99M-56.02%19.43M-215.89%-61.79M63.33%58.08M-20.66%30.27M54.91%171.23M-1.78%44.19M49.25%53.32M286.83%35.56M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More